# Óskare Capital

Óskare Capital is a Venture Capital based in Paris, France.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Paris, France
- **Region:** Europe
- **Address:** 108 avenue Felix Faure, 75015 Paris, France
- **Founded:** 2018
- **Assets under management:** Undisclosed
- **Website:** oskarecapital.com
- **LinkedIn:** https://linkedin.com/company/oskare-capital

## Regulatory record

- **Reports private funds:** No

## About

Oskare Capital invests in medical cannabinoid companies and teams. The firm has made 7 investments, including a Series A - II investment in Octarine Bio on January 22, 2026. Founded by Alexandre Ouimet-Storrs.

## Sectors

- Life Sciences
- Deep Tech
- Digital Health
- Industrial Biotech

## Offices

- London, United Kingdom

## Questions

### What is Óskare Capital's core investment thesis?

Óskare Capital concentrates on early-stage European deeptech and life sciences companies, with a specific focus on synthetic biology, neurological drug development, chronic pain treatment, and botanical extraction technology. Its disclosed portfolio avoids generalist software and consumer internet plays.

### At which stage does Óskare Capital typically invest?

The firm primarily targets Pre-Seed and Seed rounds, with capacity to follow on at Series A or participate in post-IPO opportunities when the underlying science and team align. Its first investment in Octarine Bio was a Pre-Seed check in 2019.

### Where is Óskare Capital operationally active?

The firm is headquartered in Paris with an additional office in London. Its portfolio spans Denmark, Italy, the UK, and France, with one portfolio company — Herbolea — maintaining operations in both Italy and the United States.

### How can an external investor access Óskare Capital's strategy?

Óskare Capital is currently raising Oskare Fund I, its dedicated venture vehicle. The firm invites inquiries through its website for those interested in investing in the fund or its portfolio companies.

### Does Óskare Capital participate in fund commitments or only direct deals?

Based on disclosed activity, the firm exclusively executes direct venture investments into operating companies. No fund-of-fund commitments or LP positions in other managers are publicly noted.

## Related profiles

- [OSIM International](https://altss.com/profile/osim-international)
- [OSK Ventures International](https://altss.com/profile/osk-ventures-international)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/oskare-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology